Private Equity Firms Buying Medical Practices ❲95% Exclusive❳

After a period of stabilization, healthcare private equity deal value reached an estimated , surpassing previous highs. This momentum has carried into 2026, driven by a massive "dry powder" stockpile and a pivot toward technology-enabled assets like AI-based telehealth and revenue cycle management.

This feature explores the evolving landscape of private equity (PE) acquisitions in the medical sector as of 2026. private equity firms buying medical practices

The rapid consolidation of independent medical practices under private equity ownership. After a period of stabilization, healthcare private equity

: Most deals are now "bolt-ons"—small practices acquired to expand existing large platforms—which often fall below federal reporting thresholds, leading to "stealth consolidation". 2. The Driver: Why Doctors are Selling The Driver: Why Doctors are Selling : While

: While primary care was the early focus, firms are now aggressively targeting high-margin specialties including dermatology, ophthalmology, gastroenterology, and orthopedics.

: PE provides the funds needed to upgrade electronic medical record (EMR) systems and invest in advanced diagnostic tools.

Physicians are increasingly seeking PE partnerships to navigate a complex modern landscape: